1
|
Garcia Garcia MR, Casares N, Martinez Perez LA, Juarez Curiel E, de Jesus Hernandez AA, Bogdanchikova N, Garibo D, Rodriguez-Hernandez AG, Pestryakov A, Castro Gamboa S, Arias Ruiz LF, Torres Bugarin O, Berraondo P. Silver nanoparticles induce a non-immunogenic tumor cell death. J Immunotoxicol 2023; 20:2175078. [PMID: 36773297 DOI: 10.1080/1547691x.2023.2175078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023] Open
Abstract
Immunogenic cell death (ICD) is a form of cell death characterized by the release of danger signals required to trigger an adaptive immune response against tumor-associated antigens. Silver nanoparticles (AgNP) display anti-proliferative and cytotoxic effects in tumor cells, but it has not been previously studied whether AgNP act as an ICD inductor. The present study evaluated the in vitro release of calreticulin as a damage-associated molecular pattern (DAMP) associated with the cytotoxicity of AgNP and their in vivo anti-cancer effects. In vitro, mouse CT26 colon carcinoma and MCA205 fibrosarcoma cells were exposed to AgNP and then cell proliferation, adhesion, and release of calreticulin were determined. The results indicated there were time- and concentration-related anti-proliferative effects of AgNP in both the CT26 and MCA205 lines. Concurrently, changes in cell adhesion were detected mainly in the CT26 cells. Regarding DAMP detection, a significant increase in calreticulin was observed only in CT26 cells treated with doxorubicin and AgNP; however, no differences were found in the MCA205 cells. In vivo, the survival and growth of subcutaneous tumors were monitored after vaccination of mice with cell debris from tumor cells treated with AgNP or after intra-tumoral administration of AgNP to established tumors. Consequently, anti-tumoral prophylactic immunization with AgNP-dead cells failed to protect mice from tumor re-challenge; intra-tumor injection of AgNP did not induce a significant effect. In conclusion, there was a noticeable anti-tumoral effect of AgNP in vitro in both CT26 and MCA205 cell lines, accompanied by the release of calreticulin in CT26 cells. In vivo, immunization with cell debris derived from AgNP-treated tumor cells failed to induce a protective immune response in the cancer model mice. Clearly, further research is needed to determine if one could combine AgNP with other ICD inducers to improve the anti-tumor effect of these nanoparticles in vivo.
Collapse
Affiliation(s)
- Maritza Roxana Garcia Garcia
- Academic Unit of Health Sciences, Department of Health Sciences, Autonomous University of Guadalajara (UAG), Guadalajara, Jalisco, Mexico
| | - Noelia Casares
- Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.,Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
| | - Luz Andrea Martinez Perez
- Institute of Biosciences Research, Los Altos University Center (CUAltos), University of Guadalajara (UDG), Tepatitlán de Morelos, Jalisco, Mexico
| | - Efren Juarez Curiel
- Laboratory of Molecular Biology, Technological Institute of Tlajomulco (ITT), Tlajomulco de Zuñiga, Jalisco, Mexico
| | - Andres Alberto de Jesus Hernandez
- Academic Unit of Health Sciences, Department of Health Sciences, Autonomous University of Guadalajara (UAG), Guadalajara, Jalisco, Mexico
| | - Nina Bogdanchikova
- Department of Physical Chemistry of Nanomaterials, Centre of Nanosciences and Nanotechnology, Autonomous University of Mexico (UNAM), Ensenada, Baja California, México
| | - Diana Garibo
- Research Fellow at Department of Bionanotechnology, CNyN, UNAM, Ensenada, Baja California Norte, Mexico
| | - Ana G Rodriguez-Hernandez
- Research Fellow at Department of Bionanotechnology, CNyN, UNAM, Ensenada, Baja California Norte, Mexico
| | | | - Sandra Castro Gamboa
- Laboratory of Evaluation of Genotoxic Damage. Department of Internal Medicine II, School of Medicine, UAG, Guadalajara, Jalisco, México
| | - Luis Felipe Arias Ruiz
- Laboratory of Evaluation of Genotoxic Damage. Department of Internal Medicine II, School of Medicine, UAG, Guadalajara, Jalisco, México
| | - Olivia Torres Bugarin
- Laboratory of Evaluation of Genotoxic Damage. Department of Internal Medicine II, School of Medicine, UAG, Guadalajara, Jalisco, México
| | - Pedro Berraondo
- Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.,Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.,Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain
| |
Collapse
|